IV Antibiotics for Patients with Cellulitis

Size: px
Start display at page:

Download "IV Antibiotics for Patients with Cellulitis"

Transcription

1 Policy Number LCH-93 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational change this FRONT COVER has been added so the reader is aware of any changes to their role or to terminology which has now been superseded. When reading this document please take account of the changes highlighted in Part B and C of this form. Part A Information about this Document Policy Name IV Antibiotics for Patients with Cellulitis Policy Type Board Approved (Trust-wide) Trust-wide Divisional / Team / Locality Action No Change Minor Change Major Change New Policy No Longer Needed Approval As Mersey Care s Executive Director / Lead for this document, I confirm that this document: a) complies with the latest statutory / regulatory requirements, b) complies with the latest national guidance, c) has been updated to reflect the requirements of clinicians and officers, and d) has been updated to reflect any local contractual requirements Signature: Date: Part B Changes in Terminology (used with Minor Change, Major Changes & New Policy only) Terminology used in this Document New terminology when reading this Document Part C Additional Information Added (to be used with Major Changes only) Section / Paragraph No Outline of the information that has been added to this document especially where it may change what staff need to do Part D Rationale (to be used with New Policy & Policy No Longer Required only) Please explain why this new document needs to be adopted or why this document is no longer required Part E Oversight Arrangements (to be used with New Policy only) Accountable Director Recommending Committee Approving Committee Next Review Date LCH Policy Alignment Process Form 1

2 SUPPORTING STATEMENTS This document should be read in conjunction with the following statements: SAFEGUARDING IS EVERYBODY S BUSINESS All Mersey Care NHS Foundation Trust employees have a statutory duty to safeguard and promote the welfare of children and adults, including: being alert to the possibility of child / adult abuse and neglect through their observation of abuse, or by professional judgement made as a result of information gathered about the child / adult; knowing how to deal with a disclosure or allegation of child / adult abuse; undertaking training as appropriate for their role and keeping themselves updated; being aware of and following the local policies and procedures they need to follow if they have a child / adult concern; ensuring appropriate advice and support is accessed either from managers, Safeguarding Ambassadors or the trust s safeguarding team; participating in multi-agency working to safeguard the child or adult (if appropriate to your role); ensuring contemporaneous records are kept at all times and record keeping is in strict adherence to Mersey Care NHS Foundation Trust policy and procedures and professional guidelines. Roles, responsibilities and accountabilities, will differ depending on the post you hold within the organisation; ensuring that all staff and their managers discuss and record any safeguarding issues that arise at each supervision session EQUALITY AND HUMAN RIGHTS Mersey Care NHS Foundation Trust recognises that some sections of society experience prejudice and discrimination. The Equality Act 2010 specifically recognises the protected characteristics of age, disability, gender, race, religion or belief, sexual orientation and transgender. The Equality Act also requires regard to socio-economic factors including pregnancy /maternity and marriage/civil partnership. The trust is committed to equality of opportunity and anti-discriminatory practice both in the provision of services and in our role as a major employer. The trust believes that all people have the right to be treated with dignity and respect and is committed to the elimination of unfair and unlawful discriminatory practices. Mersey Care NHS Foundation Trust also is aware of its legal duties under the Human Rights Act Section 6 of the Human Rights Act requires all public authorities to uphold and promote Human Rights in everything they do. It is unlawful for a public authority to perform any act which contravenes the Human Rights Act. Mersey Care NHS Foundation Trust is committed to carrying out its functions and service delivery in line the with a Human Rights based approach and the FREDA principles of Fairness, Respect, Equality Dignity, and Autonomy Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 2 of 25

3 Policy for the Administration of Intravenous Antibiotics via a Patient Group Direction (PGD) in the Community for Patients with Cellulitis who are referred by Liverpool General Practitioners (GP) POLICY 93 Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 3 of 25

4 Title Policy reference number Aim and purpose of clinical document Author s title Policy for the Administration of Intravenous Antibiotics via a Patient Group Direction (PGD) in the Community for Patients with Cellulitis who are referred by Liverpool General Practitioners (GP) 93 The aim of the Policy is to provide framework for all qualified nurses within the Intravenous Therapy Team to provide a Patient Group Direction (PGD) driven service to ensure quality and consistency in the delivery of clinical care to patients requiring IV antibiotics for Cellulitis. Sara Caddick Medicines Management Pharmacist Type New document x Reviewed document Review date January 2020 Person/ group accountable for review Type of evidence base used IV Therapy Team C: Evidence which includes published and/or unpublished studies and expert opinion Issue date January 2018 Authorised by Clinical Standards Group Impact Assessment Undertaken 24 th January 2018 Yes X Date: 17/01/18 Evidence collated No Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 4 of 25

5 Version Number: Ratified by: V5 Clinical Standards Group Date of Approval: 24 th January 2018 Name of originator/author: Approving Body / Committee: IV Therapy Nurse Clinical Standards Group Date issued (Current version): January 2018 Review date (Current Version): January 2020 Target Audience: Name of Lead Director / Managing Director: Changes / Alterations Made To Previous Version: Director of Nursing Policy reference numbers 4 & 5 merged to create this policy Converting guideline to policy Change in title to include PGD Updated policy to include new Inclusion/Exclusion Criteria Updated policy for change in time deadline for same day treatment Change in referral form Changes in formatting Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 5 of 25

6 Key individuals involved in developing the document Name Designation Alison Smith IV Therapy Operational/Professional Lead. Liverpool Community Health NHS Trust. Christine Roberts Dr Emmanuel Nsutebu Dr Jonathon Folb Dr Richard Cooke Dr Peter Chamberlain Sue Wright Emma Hughes IV Team Leader. Liverpool Community Health NHS Trust. Infectious Diseases Consultant. Royal Liverpool and Broadgreen University Hospital NHS Trust. Consultant Microbiologist Royal Liverpool and Broadgreen University Hospital NHS Trust. Consultant Microbiologist. Aintree University Hospital NHS Foundation Trust. Clinical lead for strategy and innovation. South Sefton CCG Pharmacist. Liverpool Community Health NHS Trust Anti-infective Pharmacist. Aintree University Hospital NHS Foundation Trust This current document was circulated to the following individuals for consultation Name Dr Jonathon Folb Emma Hughes Anne Neary Tom Blanchard Designation Consultant Microbiologist Royal Liverpool and Broadgreen University Hospital NHS Trust. Anti-infective Pharmacist Lead for Liverpool Community Health Anti-infective Pharmacist Royal and Broadgreen University Hospital NHS Trust Consultant Microbiologist Royal and Broadgreen University Hospital NHS Trust Microbiologist for OPAT Page 6 of 25

7 Contents Section Page 1 Introduction 6 2 Purpose of the Guideline Scope of the Guidelines 6 3 Definitions 7 4 Duties and Responsibilities 7 5 Policy Eligibility Criteria Exclusion Criteria Consent Responsibilities Procedures Referral Process Treatment Regimen Adverse Incidents 15 6 Training Requirements 16 7 Equality Impact Assessment 16 8 Monitoring Compliance 16 9 References 17 Appendix 1 Community IV Antibiotics Referral Form 18 Appendix 2 National Early Warning Score (NEWS) 19 Appendix 3 VIIAD Charts 20 Appendix 4 Patient Information Leaflet 22 Appendix 5 Visual Inspection Phlebitis Score (VIP) 23 Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 7 of 25

8 1. Introduction The administration of IV medication by nurses has become more widespread in recent years. The practice has now become part of the core skills for general nursing practice, allowing a holistic approach to total patient care. With today s emphasis on community care and patient empowerment, there is a growing need for community nurses to take on this role in order to facilitate home care. This policy is designed to give clarity around the management and administration of intravenous antibiotics in the community via a Patient Group Direction for the treatment of cellulitis. Administration of IV Antibiotics carries potential risks and should only be given if the benefits outweigh these risks. Stringent systems need to be in place to ensure that the correct product is given to the correct patient at the correct time and that any adverse reactions are dealt with promptly and efficiently. 2. Purpose The purpose of the policy is to ensure quality and consistency in the delivery of clinical care to patients receiving Intravenous Antibiotics for cellulitis in the community. 2.1 Scope This policy applies to all qualified nurses in the Intravenous Therapy Team within Liverpool Community Health NHS Trust and should only be used by professional registered clinical staff signed up to the Patient group Directions. T his will not be passed to District Nurses as a Patient Group Direction cannot be delegated Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 8 of 25

9 3. Definitions Community Intravenous (IV) Cannula Deep Vein Thrombosis TPR + BP GP AMU/MAU WIC SPC USS Out of hours - Liverpool VIIAD PGD AKI RR Refers to community clinics, the patient s own home, residential and nursing homes Refers to administering the antibiotic directly into the vein Refers to the short peripheral device through which the antibiotics are given directly into the vein Refers to a blood clot in one of the deep veins in the leg Temperature, Pulse, Respiration and Blood Pressure relating to clinical condition General Practitioner Acute Medical Unit/Medical Assessment Unit Walk In Centre Single Point of Contact Ultrasound Scan After 5pm and before 08.30am seven days a week. Visual Inspection Intravenous access devices Patient Group Direction Acute Kidney Injury Respiratory Rate 4. Duties and Responsibilities Liverpool Community Health NHS Trust is responsible for Ensuring that appropriate training is in place so that qualified nurses can fulfil their duties in accordance with this policy Providing the Hepatitis B vaccine free of charge to all employees at risk of exposure to blood and body fluids in the course of their duties Senior Managers and Team Leaders are responsible for The operational implementation of this policy and associated procedures Ensuring that appropriately trained staff are used to deliver the services Ensuring that a planned audit cycle is in place Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 9 of 25

10 Registered health practitioners are responsible for Securing the Hepatitis B vaccine series Observing standard infection control precautions in particular hand hygiene, wearing of protective clothing and safe handling and disposal of sharps Complying with the requirements of all relevant NHS Liverpool Community Health policies applicable to their area of operation Complying with the requirements (including training and sign off from an authorised peer) of all relevant Liverpool Community Health Patient Group Directions applicable to the area of operation Reporting all potential adverse incidents in line with Liverpool Community Health Risk Management Policy (including serious untoward incidents) Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 10 of 25

11 5. Policy 5.1 Eligibility Criteria The clinician responsible for care must use their professional judgement to determine the appropriateness of the individual patient for IV therapy via the PGD Cellulitis service based on the following criteria: The medical/ psychological condition of the patient is suitable and stable and does not require complex nursing/ medical interventions or care Over 18 years of age Registered with a Liverpool GP Medically Stable and GP satisfied that are within the following Clinical Parameters:* Respiratory Rate 9 and 20 Oxygen Saturations 92% (88% in COPD) Temperature 35 o C and 39 o C Systolic BP 90 mmhg and 200 mmhg (or 40 mmhg drop below normal) Heart Rate 50 bpm and 110 bpm Alert and Orientated *Based on National Early Warning Score (NEWS) Aggregate 0-4 and Sepsis Screening Tool Satisfactory home conditions exist, including access to either a landline telephone or a mobile connection The patient/carer/family understands the implications of the treatment and how to recognise and report potential complications relating to treatment Patients meeting eligibility criteria will need to be referred into the service using the Community IV Antibiotics Referral Form (see Appendix 1) A Homeless person would not be automatically declined. The IV Therapy Team would endeavour to establish a safe haven to administer therapy Page 11 of 25

12 5.2 Exclusion Criteria Under 18 years of age Not registered with a Liverpool GP History of anaphylactic reaction to intended antibiotics Medically unstable and are out-side the following Clinical Parameters* Respiratory Rate <9 and >20 Oxygen Saturations <92% (88% in COPD) Temperature <35 o C and >39 o C Systolic BP <90 mmhg and >200 mmhg (or 40 mmhg drop below normal) Heart Rate <50 bpm and >110 bpm Not Alert and Orientated *Based on National Early Warning Score (NEWS) Aggregate 5 and Sepsis Screening Tool (Appendix 2) Acute drug or alcohol misuse Suspected DVT Critical Ischaemia requiring surgical assessment Uncontrolled diabetes at risk of complications including Diabetic Foot Ulcers egfr<20 requires discussion with Infectious Diseases Consultant/ Medical Microbiology Unable to cope at home or unsuitable home conditions. Cellulitis of face or periorbital cellulitis Signs and symptoms of cellulitis suggesting joint involvement. Pain disproportionate to skin colour changes Human or animal bite Pregnancy or breast feeding - this is an exclusion for PGD purposes. GP wishing to refer would refer via the IV Antibiotic Policy 025 Note: GP wishing to refer a patient who meets exclusion criteria may do so if he retains the medical and prescribing responsibility as per IV Antibiotic Policy 25. Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 12 of 25

13 5.3 Consent Informed consent must be obtained before any procedure is undertaken. Every adult has the right to make their own decisions and must be assumed to have capacity to do so unless it is proved otherwise. 5.4 Responsibilities General Practitioner will be responsible for: Any unrelated medical conditions Liaising with Medical Microbiology if required The responsibilities of the Intravenous Therapy Team will be: To advise regarding suitability for treatment in the community To provide advice and information to patients concerning the condition, treatment and follow up including emergency telephone numbers To care for intravenous access devices in accordance with NHS Liverpool Community Health clinical guidance documents and corporate policies To cannulate or insert midline venous access devices To alert medical staff to any reaction to the antibiotics and report according to the yellow card scheme To be a point of contact for professional advice, support and training for patients and District Nurses To collate the results of blood tests and alert the patient s GP of any significant event. To maintain accurate records, reviewing care pathway of each patient receiving care from the Community Intravenous Therapy Team Enter clinical information contemporaneously on EMIS and hand held patient records 5.5 Procedures Peripheral cannulation see Policy 102 Insertion of Midline devices Administration of intravenous medication via bolus - see CINS policy Administration of intravenous medication via intermittent infusion see CINS policy Administration of intravenous medication via continuous infusion see CINS policy Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 13 of 25

14 Management of phlebitis and infiltration Management of extravasation Intravenous Antibiotic Policy see Policy Referral Process GP to refer if they meet the criteria for home treatment GP to discuss with Infectious Diseases Consultant/ Medical Microbiology if require specific advice If patients do not meet criteria for home treatment, then GP is to consider admission to Secondary care SPC will highlight the services of the IV Team to the GP as an option of care If the GP initially suspects a Deep Vein Thrombosis then the patient will be referred via UCD for further tests Referrals for same day treatment must be received by 1pm, otherwise treatment will commence the following working day Patients will be referred by the GP to the IV Team via the following route: a) Firstly contacting UCD/SPC. Telephone Number No b) By faxing the GP referral form (see Appendix 1) via the safe haven fax machine located within the office c) If a Clinical conversation is required with the IV Team then they can be contacted on telephone No Treatment Regimen The Intravenous Therapy Team will on the first visit take blood for the FBC, U&E and Random Glucose Wound swabs will be taken if a wound is present (the purpose of the wound swab is to ascertain whether the bacteria in the wound has caused the cellulites) Cellulitis boundaries will be marked with a surgical marker If the patient has tachycardia and has an increased respiratory rate this may be an indication of sepsis. The patient must be referred to Secondary Care by the Intravenous Therapy Team The Intravenous Therapy Team will discuss with GP if patient is experience any hearing problems as patients may require auditory assessment. This is because Teicoplanin may cause tinnitus, mild Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 14 of 25

15 hearing loss or vestibular disorder Written consent will need to be obtained using a Consent Form or verbal consent by the Intravenous Therapy Team. The purpose of this is for the patient to provide consent to the treatment with intravenous antibiotics at home and to be informed of the benefits and risks The Intravenous Therapy Team will cannulate the patient IV Antibiotics will be supplied and administered as per PGD Patient will be reviewed by the IV Team on day 4 for step down antibiotic therapy with 7 days oral therapy to ensure infection is resolving If egfr is then normal Teicoplanin dosing is recommended If egfr is <20 during treatment then advice should be sought by Infectious Diseases Consultant/Medical Microbiology Consultant and the patient needs to be referred back to a prescriber. Treatment does NOT continue under a PGD Home treatment is not recommended for patients with Acute Kidney Injury (AKI) If the infection is not resolving on day 4 and step down to oral antibiotic therapy is not appropriate, the patient needs to be referred back to a prescriber. Treatment does NOT continue under a PGD DRUG DOSE FREQUENCY DURATION ROUTE Ceftriaxone 2 Grams Once a day 3 Days IV Followed by DRUG DOSE FREQUENCY DURATION ROUTE Flucloxacillin 500mg Four times a day 7 days Oral Amoxycillin 500mg Three times a day 7 days Oral Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 15 of 25

16 If Penicillin Allergic DRUG DOSE FREQUENCY DURATION ROUTE Teicoplanin 800mg Once a day 3 days IV Followed by DRUG DOSE FREQUENCY DURATION ROUTE Clindamycin 450 mg Four times a day 7 days Oral If DVT is suspected the IV Therapy Team will discuss with the GP. The patient will need to follow the DVT pathway for Liverpool patients and needs to be referred back to a prescriber. Treatment does NOT continue under a PGD The IV Team will monitor the patient s condition using the National Early Warning Score (NEWS) daily Cellulitis boundaries will be reviewed daily and re-marked accordingly Blood tests will be taken as indicated The cannula site will be observed daily for signs of phlebitis using the VIIAD score (Appendix 3). Patients will be re-cannulated as required refer to Policy 25 IV Antibiotics. The intravenous dressing will be changed following re-cannulation or if dressing is soiled At each visit the IV Team will advise the patient should they feel unwell out of hours that they should contact the Medical Assessment Unit at Royal and Broadgreen Hospital on The patient will be educated on care of the cannula and a leaflet will be provided with contact details if they have problems with their cannula. (Appendix 4) The IV Team will liaise with GP / Medical Microbiology / Infectious Diseases Consultant regarding patients whom develop signs of extending cellulitis. If required patients can be reviewed on AMU as a ward attendee If the GP needs advice then a Senior Medical Microbiologist is available 24 hours a day. They can be contacted via the Royal Liverpool and Broadgreen Hospital Trust (RLBUHT) switchboard on or Aintree University Hospital Foundation Trust on If there are signs of vascular access device infection this will be reported to the Infection Control Team by the IV Team and an incident form will be completed via the Trusts electronic incident reporting system Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 16 of 25

17 Any infections or problems relating to vascular access devices will be audited If a wound is present then the patient will be referred to their District Nurses for on-going management Adverse reactions will be reported according to the yellow card scheme available on-line on or on Trusts Homepage The cannula will be removed at the end of the IV treatment 5.8 Adverse incidents All patients with an intravenous access device in place must have the IV site checked daily or on each shift for signs of infusion phlebitis. The subsequent score and action(s) taken (if any) must be documented. Use the VIADD and VIP score (see appendix 3 and 5). The IV site must also be observed: When bolus injections are administered IV flow rates are checked or altered When solution containers are changed The incidence of infusion phlebitis varies; the following Good Practice Points may assist in reducing the incidence of infusion phlebitis: Observe IV site at least daily Secure venous access device with a proven highly permeable intravenous dressing Replace loose, contaminated dressings Venous access device must be inserted away from joints whenever possible Aseptic technique must be followed Active consideration must be given to re-siting the cannula every hours as per IV Antibiotic Policy. If the line is compromised or the dressing soiled this must be changed every 24 hours as per policy Plan and document continuing care Use the smallest gauge cannula most suitable for the patient s need Replace the cannula at the first indication of infusion phlebitis (stage 2 on the VIP score See Appendix 5) Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 17 of 25

18 6. Training Requirements All members of the IV Team receive the level of training necessary for them to fulfil their individual responsibilities identified in this policy and have responsibility for maintaining their competencies. Before undertaking IV therapy administration, health care practitioners should ensure that they have attended an annual update of management of anaphylaxis and CPR within the last year. Before undertaking medication administration via a Patient Group Direction (PGD), the staff involved must have completed PGD training and assessment. This requires to be renewed every 2 years. With regards to the PGD for Cellulitis they need to have read, understood and signed the PGD. 7. Equality Impact Assessment The Equality Impact Assessment was assessed on 17/01/17 8. Monitoring Compliance This policy will be monitored by the number of incidents reported by the Trusts on-line incident reporting system relating to: Patient/carer satisfaction Incidents relating to infections linked with cannula Results from weekly point of prevalence audits on cannulas and insertion sites Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 18 of 25

19 9. References The following guidance was used in the production of this document: Royal College of Nursing October 2003 Standards for Infusion Therapy Nursing and Midwifery Council April `Standards for Medicine Management`(2008) Nursing and Midwifery Council ( March 2015) The Code CINS guidelines Care and Maintanence of Venous Access Devices Pan Mersey Antimicrobial Guidelines and Management of Common Infections in Primary Care 2015/16 Pratt et al; National evidence-based guidelines for preventing healthcareassociated infections in NHS hospitals in England; Journal of Hospital Infection (2007) 65S, S1-s64, 5 th February 2007 National Early Warning Score (NEWS) 2 RCP London last accessed 18/01/18 at Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 19 of 25

20 Appendix 1 Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 20 of 25

21 Appendix 2 Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 21 of 25

22 Appendix 3 VIIAD Charts Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 22 of 25

23 Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 23 of 25

24 Appendix 4 Patient Information Leaflet Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 24 of 25

25 Appendix 5 Visual Inspection Phlebitis Score (VIP) Policy for the administration of intravenous antibiotics via a PGD in the community for patients with cellulitis who are referred by Liverpool GPs Page 25 of 25

Major Change. Outline of the information that has been added to this document especially where it may change what staff need to do

Major Change. Outline of the information that has been added to this document especially where it may change what staff need to do Policy Number LCH-45 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational

More information

Patient Self Administration of Intravenous (IV) Antibiotics at Home

Patient Self Administration of Intravenous (IV) Antibiotics at Home Trust Policy Document Ref. No: PP(16)319 Patient Self Administration of Intravenous (IV) Antibiotics at Home For use in: For use by: For use for: Document owner: Status: Clinical Areas Clinical Staff Patient

More information

MANAGEMENT OF ASBESTOS

MANAGEMENT OF ASBESTOS TRUST-WIDE NON-CLINICAL POLICY DOCUMENT MANAGEMENT OF ASBESTOS Policy Number: Scope of this Document: Recommending Committee: Approving Committee: HS9 All Staff, patients/service users, visitors and contractors

More information

OPAT CELLULITIS PATHWAY

OPAT CELLULITIS PATHWAY OPAT CELLULITIS PATHWAY ANY exclusion criteria for OPAT Sepsis syndrome Active drug/alcohol abuse Active underlying orthopaedic condition Craniofacial cellulitis Failure to improve with > 48hrs IV Rx YES

More information

Health & Social Services

Health & Social Services The States of Jersey Department for Health & Social Services AGREED PROCESS FOR COMMUNITY INTRAVENOUS THERAPY Date approved DOCUMENT PROFILE Document Registration Document Purpose Short Title Author Publication

More information

Subcutaneous Rehydration Guidelines

Subcutaneous Rehydration Guidelines Policy Number LCH-85 This document has been reviewed in line with the Policy Alignment Process for Liverpool Community Health NHS Trust Services. It is a valid Mersey Care document, however due to organisational

More information

Code of Guidance for Private Practice for Consultants and Speciality Doctors

Code of Guidance for Private Practice for Consultants and Speciality Doctors TRUST-WIDE CLINICAL GUIDANCE DOCUMENT Code of Guidance for Private Practice for Consultants and Speciality Doctors Policy Number: Scope of this Document: Recommending Committee: Approving Committee: HR-G7

More information

Community Intravenous Therapy Referral Standards

Community Intravenous Therapy Referral Standards pecialist harmacy ervice Medicines Use and afety Community Intravenous Therapy Referral tandards Background A multi-centred audit of prescribing and administration of community IV therapy across East and

More information

The School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT

The School Of Nursing And Midwifery. CLINICAL SKILLS PASSPORT The School Of Nursing And Midwifery. BMedSci Nursing (Adult) CLINICAL SKILLS PASSPORT Student Details NAME: COHORT: I understand that this booklet may be reviewed by my mentor, the programme leader, my

More information

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework

Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Registered Nurse Intravenous Therapy and Peripheral Cannulation Competency Framework Name: Location: Date commenced: Contents Competency: Page No: Page 1. Core: Introduction Demonstrate knowledge that

More information

Chemotherapy Practice Competencies. To be used in conjunction with Teesside University module:

Chemotherapy Practice Competencies. To be used in conjunction with Teesside University module: Chemotherapy Practice Competencies To be used in conjunction with Teesside University module: AHH3088-N - Chemotherapy Enhancing Practice in Cancer Care School of Health & Social Care NAME. PLACE OF WORK

More information

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure

Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure Administration of IV Medication in the Community by the Children s Community Nursing Team Standard Operating Procedure DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Quality and Standards Group Date

More information

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD)

CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) CLINICAL PROTOCOL FOR THE DEVELOPMENT AND IMPLEMENTATION OF PATIENT GROUP DIRECTIONS (PGD) DEFINITION A Patient Group Direction (PGD) is a specific written instruction for the supply and administration

More information

Document Details. notification of entry onto webpage

Document Details.  notification of entry onto webpage Document Details Title Patient Group Direction (PGD) Administration of sodium chloride 0.9% injection by registered professionals Trust Ref No 1987-38096 Local Ref (optional) Main points the document As

More information

Sepsis guidance implementation advice for adults

Sepsis guidance implementation advice for adults Sepsis guidance implementation advice for adults NHS England INFORMATION READER BOX Directorate Medical Operations and Information Specialised Commissioning Nursing Trans. & Corp. Ops. Strategy & Innovation

More information

Managing Community Access and the management of appointments

Managing Community Access and the management of appointments TRUST-WIDE CLINICAL POLICY DOCUMENT Managing Community Access and the management of appointments Policy Number: Scope of this Document: Recommending Committee: Approving Committee: SD08 All Staff Trust

More information

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary.

Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Clinical Guideline for Nurse-Led Indocyanine Green Angiography Summary. Obtain brief medical history including allergies & renal function. Informed verbal consent gained and documented and procedure and

More information

GP Promotional Pack. Sunderland Community Non-complicated Cellulitis Pathway. (Eron s Class II) Revised Version following RPIW JUNE 2015

GP Promotional Pack. Sunderland Community Non-complicated Cellulitis Pathway. (Eron s Class II) Revised Version following RPIW JUNE 2015 GP Promotional Pack Sunderland Community Non-complicated Cellulitis Pathway (Eron s Class II) Revised Version following RPIW JUNE 2015 Version 3- Revised pathway following RPIW June 2015 Contents Section

More information

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019

Patient Group Direction for Aspirin 300mg Version: 02 Start Date: 1 st October 2017 Expiry Date: 30 th September 2019 THIS PATIENT GROUP DIRECTION HAS BEEN AGREED BY THE FOLLOWING ORGANISATIONS: CLINICAL COMMISSIONING GROUP: Doncaster CCG, Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire

More information

Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian

Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian NHS Grampian Patient Group Direction For The Administration Of Sodium Chloride (0.9%) Via Nebulisation By Physiotherapists Working Within NHS Grampian Lead Author: Consultation Group: Approver: Highly

More information

GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2017/1426 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Immunisation

More information

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1

Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 Managing medicines in care homes Social care guideline Published: 14 March 2014 nice.org.uk/guidance/sc1 NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-ofrights).

More information

PATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix )

PATIENT GROUP DIRECTION. Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) PATIENT GROUP DIRECTION Administration of: By: Practice Nurses Hepatitis A + B Vaccine (Twinrix, Twinrix paediatric, Ambirix ) In: General Practice It is the responsibility of the professional working

More information

Central Alerting System (CAS) Policy

Central Alerting System (CAS) Policy Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified By Central Alerting System (CAS) Policy NTW(O)17 Gary O Hare Executive Director of Nursing and Operations Tony Gray

More information

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Fitzwilliam Hospital Milton Way, South Bretton, Peterborough,

More information

Management of Adults with Lower Limb Cellulitis

Management of Adults with Lower Limb Cellulitis Management of Adults with Lower Limb Cellulitis Community IV Therapy Team Guideline (Brighton and Hove area) Parent Policy / Policies Intravenous therapy administration for adults and children Medicines

More information

Wandsworth CCG. Continuing Healthcare Commissioning Policy

Wandsworth CCG. Continuing Healthcare Commissioning Policy Wandsworth CCG Continuing Healthcare Commissioning Policy Document Control Title Originator/author: Approval Body Wandsworth CCG Continuing Healthcare Commissioning Policy Alison Kirby / Munya Nhamo Wandsworth

More information

DISTRICT NURSING and INTERMEDIATE CARE

DISTRICT NURSING and INTERMEDIATE CARE CLINICAL GUIDELINES DISTRICT NURSING and INTERMEDIATE CARE Schedule of guidelines attached: DNICT03 Community Procedure for the Administration of Intravenous Drugs via Bolus The guidelines scheduled above

More information

Expiry Date: January 2009 Template Version: Page 1 of 7

Expiry Date: January 2009 Template Version: Page 1 of 7 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Exclusion criteria: Cautions/Need for

More information

Setting up and running a community IV therapy clinic

Setting up and running a community IV therapy clinic Setting up and running a community IV therapy clinic Moving care to the community has been a UK-wide health and social care priority for more than a decade (Royal College of Nursing [RCN], 2013). With

More information

Hepatitis B Immunisation procedure SOP

Hepatitis B Immunisation procedure SOP Hepatitis B Immunisation Procedure SOP Standard Operating Procedure (SOP) Ref No: 1992 Version: 3 Prepared by: Karen Bennett Presented to: Care and Clinical Policies Sub Group Ratified by: Care and Clinical

More information

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES

CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES CLINICAL PROTOCOL FOR COMMUNITY PODIATRY PATIENTS WITH TYPE II DIABETES RATIONALE Access to Community Podiatry services and treatment intervals for Diabetic patients, will generally be determined by the

More information

Tissue Viability Referral Pathway. April 2017

Tissue Viability Referral Pathway. April 2017 Tissue Viability Referral Pathway V4 April 2017 Table of Contents 1. Introduction... 3 2. Purpose of this Policy/Procedure... 3 3. Scope... 3 4. Definitions / Glossary... 3 5. Ownership and Responsibilities...

More information

Standards of Practice for Optometrists and Dispensing Opticians

Standards of Practice for Optometrists and Dispensing Opticians Standards of Practice for Optometrists and Dispensing Opticians effective from April 2016 Standards of Practice for Optometrists and Dispensing Opticians Standards of Practice Our Standards of Practice

More information

Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT)

Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT) Birmingham, Sandwell and Solihull Eligibility Criteria Policy for NHS Non-Emergency Patient Transport (NEPT) Version: 0.1 Ratified by: Date ratified: 1 st June 2016 Name of originator/author: Name of responsible

More information

SAFEGUARDING ADULTS COMMISSIONING POLICY

SAFEGUARDING ADULTS COMMISSIONING POLICY SAFEGUARDING ADULTS COMMISSIONING POLICY Director Responsible: Responsible person Target Audience: Name of Responsible Committee Nursing Matt O Connor Safeguarding Adults Lead All NHSBA staff and contractors

More information

DETERIORATING PATIENT POLICY GENERAL POLICY NO. 50

DETERIORATING PATIENT POLICY GENERAL POLICY NO. 50 DETERIORATING PATIENT POLICY GENERAL POLICY NO. 50 Applies to: Committee for Approval Date of Approval September 2012 Date Ratified: September 2012 Review Date: September 2015 Name of Lead Manager Version:

More information

AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy

AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and Examination Policy AMPH-PGN-10 Practice Guidance Note Intramuscular Injection (IMI) V01 Date Issued Planned Review PGN No: Issue 1 Sep 2017 Sep 2020 AMPH-PGN-10 (Part of NTW(C)29 Trust Standard for Physical Assessment and

More information

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019

Patient Group Direction for ACICLOVIR (Version 02) Valid From 1 October September 2019 Version Control This PGD has been agreed by the following organisations FCMS PDS Medical Doncaster CCG Lancashire CCGs including East Lancashire, Fylde and Wyre and North Lancashire CCGs Change history

More information

PROCEDURE FOR TAKING A WOUND SWAB

PROCEDURE FOR TAKING A WOUND SWAB CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles

More information

Non Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer

Non Attendance (Did Not Attend-DNA ) Policy. Executive Director of Nursing and Chief Operating Officer Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Non Attendance (Did Not Attend-DNA) NTW(C)06 Executive Director of Nursing and Chief Operating Officer Ann Marshall

More information

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.

Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered

More information

Job Title Name Signature Date

Job Title Name Signature Date Supply of Fluconazole 150mg capsule by Community Pharmacists working in Forth Valley Pharmacies under NHS Minor Ailment Service. Protocol Number 125 Version 5 Date protocol prepared: November 2014 Date

More information

CONSENT TO EXAMINATION OR TREATMENT

CONSENT TO EXAMINATION OR TREATMENT TRUST-WIDE CLINICAL POLICY DOCUMENT CONSENT TO EXAMINATION OR TREATMENT Policy Number: Scope of this Document: Recommending Committee: Approving Committee: SD06 All Staff Patient Safety Committee Executive

More information

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy

The Newcastle Upon Tyne Hospitals NHS Foundation Trust. Unlicensed Medicines Policy The Newcastle Upon Tyne Hospitals NHS Foundation Trust Unlicensed Medicines Policy Version.: 2.4 Effective From: 13 October 2016 Expiry Date: 13 October 2018 Date Ratified: 12 October 2016 Ratified By:

More information

NHS Constitution summary of rights and responsibilities

NHS Constitution summary of rights and responsibilities NHS Constitution summary of rights and responsibilities The Health Act 2009 which received Royal Assent in November 2009, places a legal responsibility upon all providers and commissioners of NHS care

More information

IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE

IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE Art & science The acute district synthesis care nursing of art and science is lived by the nurse in the nursing act JOSEPHINE G PATERSON IMPLEMENTING A NURSE-LED COMMUNITY INTRAVENOUS ANTIBIOTIC SERVICE

More information

CLINICAL PROTOCOL National Early Warning Score (NEWS) Observation Chart

CLINICAL PROTOCOL National Early Warning Score (NEWS) Observation Chart CLINICAL PROTOCOL National Early Warning Score (NEWS) Observation Chart November 2014 1 Document Profile Type i.e. Strategy, Policy, Procedure, Guideline, Protocol Title Category i.e. organisational, clinical,

More information

SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE DEPARTMENT OF IV THERAPY (IV THERAPISTS)

SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE DEPARTMENT OF IV THERAPY (IV THERAPISTS) UNIT: SARASOTA MEMORIAL HOSPITAL STANDARDS OF CARE STANDARDS OF PRACTICE DEPARTMENT OF IV THERAPY (IV THERAPISTS) STANDARD #: EFFECTIVE DATE: REVISED DATE: STANDARD TYPE: 04/91 5/05, 3/08 DEPARTMENTAL

More information

Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013

Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013 Framework for managing performer concerns NHS (Performers Lists) (England) Regulations 2013 Information reader box NHS England INFORMATION READER BOX Directorate Medical Operations Patients and Information

More information

POLICY FOR TAKING BLOOD CULTURES

POLICY FOR TAKING BLOOD CULTURES Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)

More information

Non-Medical Prescribing Passport. Reflective Log And Information

Non-Medical Prescribing Passport. Reflective Log And Information Non-Medical Prescribing Passport Reflective Log And Information Non-Medical Prescribing Continued Profession Development Log NMPs must refer to their regulatory bodies requirements for maintaining and

More information

Meeting the NEW RCN Standards for Infusion Therapy in practice

Meeting the NEW RCN Standards for Infusion Therapy in practice Meeting the NEW RCN Standards for Infusion Therapy in practice sumanshrestha@nhs.net Suman Shrestha MSc BSc RN Advanced Nurse Practitioner Intensive Care Frimley Park Hospital suman_sr FRIMLEY PARK HOSPITAL

More information

Unlicensed Medicines Policy

Unlicensed Medicines Policy Unlicensed Medicines Policy This procedural document supersedes: PAT/MM 4 v.3 Policy and Procedure for the Use of Unlicensed Medicines Did you print this document yourself? The Trust discourages the retention

More information

SCHEDULE 2 THE SERVICES

SCHEDULE 2 THE SERVICES SCHEDULE 2 THE SERVICES A. Service Specifications Mandatory headings 1 4: mandatory but detail for local determination and agreement Optional headings 5-7: optional to use, detail for local determination

More information

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS

THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS PGD3717 PATIENT GROUP DIRECTION FOR THESUPPLY OF METRONIDAZOLE 400mg TABLETSFOR THE TREATMENT OF BACTERIAL VAGINOSIS (BV) OR TRICHOMONAS VAGINALIS (TV) by registered nurses and midwives in Integrated Sexual

More information

Services. This policy should be read in conjunction with the following statement:

Services. This policy should be read in conjunction with the following statement: Policy Number Policy Title IT03 CORPORATE POLICY AND PROCEDURE FOR THE USE OF MOBILE PHONES BY SERVICE USERS IN IN- PATIENT AREAS Accountable Director Eecutive Director of Nursing and Secure Services Author

More information

Choice on Discharge Policy

Choice on Discharge Policy Choice on Discharge Policy Reference No: P_CIG_19 Version 1 Ratified by: LCHS Trust Board Date ratified: 13 th September 2016 Name of originator / author: Sarah McKown Name of responsible committee / Individual

More information

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019

Name Job Title Signed Date. This Patient Group Direction is operational from: Oct 2017 Review date: Aug 19. Expires on 31 st October 2019 PGD4017 PATIENT GROUP DIRECTION FOR THE SUPPLY OF ACICLOVIR TABLETS FOR THE TREATMENT OF GENITAL HERPES SIMPLEX INFECTIONS by registered nurses and midwives in Integrated Sexual Health services employed

More information

Managing medicines in care homes

Managing medicines in care homes Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience

More information

Document Details. Patient Group Direction

Document Details. Patient Group Direction Document Details Title Patient Group Direction (PGD) CO-CODAMOL 30/500 TABLETS FOR MINOR INJURIES UNITS Trust Ref No 1956-35206 Local Ref (optional) Main points the document treatment of moderate pain

More information

and colonisation suppression POLICIES REPLACING N/A

and colonisation suppression POLICIES REPLACING N/A TITLE: UNIQUE IDENTIFIER Assigned by Sharepoint VERSION No 1.2 LEAD AUTHOR S NAME Allison Charlesworth LEAD AUTHOR JOB TITLE Matron Infection Prevention ACCOUNTABLE DIRECTOR Rob Dearden, Director of Nursing

More information

Non Medical Prescribing Guidelines

Non Medical Prescribing Guidelines TRUST-WIDE CLINICAL GUIDELINES DOCUMENT Non Medical Prescribing Guidelines Policy Number: Scope of this Document: Recommending Committee: Approving Committee: MM05 All Staff Drugs and Therapeutics Committee

More information

PATIENT GROUP DIRECTION

PATIENT GROUP DIRECTION PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING

More information

Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017

Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP Version 1, June 2017 Medicine Protocol for the Administration of Inactivated Influenza Vaccine (Split Virion) BP to nurses, midwives, healthcare workers, agency staff, contract workers and volunteers by registered nurses and

More information

12. Safeguarding Enquiries: Responding to a Concern

12. Safeguarding Enquiries: Responding to a Concern 12. Safeguarding Enquiries: Responding to a Concern 1 12.1 Statutory Safeguarding Enquiries Section 42 Councils are required by law to carry out safeguarding enquiries for those individuals who meet the

More information

Anaphylactic Reaction Emergency Treatment Reference Number:

Anaphylactic Reaction Emergency Treatment Reference Number: This is an official Northern Trust policy and should not be edited in any way Anaphylactic Reaction Emergency Treatment Reference Number: NHSCT/12/551 Target audience: Nursing Staff Groups included are:

More information

CLINICAL HANDOVER AT NURSE SHIFT CHANGES

CLINICAL HANDOVER AT NURSE SHIFT CHANGES TRUST-WIDE CLINICAL DIVISION POLICY DOCUMENT CLINICAL HANDOVER AT NURSE SHIFT CHANGES Policy Number: Scope of this Document: SD49 All clinical divisions Recommending Committee: Ratifying Committee: Divisional

More information

ASEPTIC TECHNIQUE POLICY

ASEPTIC TECHNIQUE POLICY SECTION 3b ASEPTIC TECHNIQUE POLICY INFECTION CONTROL MANUAL Read in conjunction with: o Hand hygiene policy (also section 3) o Standard (Universal) Precautions policy (section 4) o Decontamination policy

More information

Principles of Shared Care Protocols

Principles of Shared Care Protocols Principles of Shared Care Protocols 1 Robust shared care arrangements facilitate the safe transition of medicines for use in a specified condition between secondary and primary care clinicians with the

More information

Document Author: Tissue Viability Nurse Date 15/02/2017

Document Author: Tissue Viability Nurse Date 15/02/2017 Guideline Title: Ref No: 1820 Version: 2 Document Author: Tissue Viability Nurse Date 15/02/2017 Ratified by: Care and Clinical Policies Group Date: 15/02/2017 Review date: 10 March 2019 Links to policies:

More information

Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition)

Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Policy for use of the Royal Marsden Manual of Clinical Nursing Procedures (9th Edition) Document Summary This Policy defines the clinical procedures for all Clinical staff (including temporary staff, contracted

More information

ADVANCE STATEMENT, ADVANCE DECISION POLICY

ADVANCE STATEMENT, ADVANCE DECISION POLICY LOCAL DIVISION CLINICAL SERVCE BASED POLICY DOCUMENT ADVANCE STATEMENT, ADVANCE DECISION POLICY Policy Number: SD 19 Scope of this Document: Recommending Committee: Appproving Committee: All staff Patient

More information

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards.

We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Inspection Report We are the regulator: Our job is to check whether hospitals, care homes and care services are meeting essential standards. Dr Abdel-Malek and Partner Sparkbrook Health Centre, 34 Grantham

More information

Inguinal hernia repair integrated care pathway (ICP)

Inguinal hernia repair integrated care pathway (ICP) Name Ward Hosp no DOB Affix patient label Inguinal hernia repair integrated care pathway (ICP) Inclusion criteria Patients undergoing inguinal hernia repair aged under 3 months corrected gestational age

More information

JOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse

JOB DESCRIPTION. Deputy Director of Nursing - Tissue Viability. Director of Nursing. Tissue Viability Support Tissue Viability Nurse JOB DESCRIPTION Job Title: Reporting to (title): Tissue Viability Nurse Specialist Deputy Director of Nursing - Tissue Viability Professionally Accountable to (title): Responsible for Supervising (if appropriate):

More information

Review of Local Enhanced Services

Review of Local Enhanced Services Review of Local Enhanced Services 1. Background and context 1.1 CCGs are required to prepare for the phasing out of LESs by April 2014 by reviewing the existing LES portfolio and developing commissioning

More information

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline

CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline CLINICAL GUIDELINE FOR THE USE OF RECTUS SHEATH CATHETERS IN CHILDREN. 1. Aim/Purpose of this Guideline 1.1. Guidelines for the use of rectus sheath catheters for the management of pain following laparotomy

More information

PATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets

PATIENT GROUP DIRECTION (PGD) FOR Metronidazole 400mg Tablets Antibiotic Oral (tablet/capsule/suspension) PATIENT GROUP DIRECTION (PGD) FOR YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Caution: This

More information

Consultation Group: See relevant page in the PGD. Review Date: October Expiry Date: October 2019

Consultation Group: See relevant page in the PGD. Review Date: October Expiry Date: October 2019 Patient Group Direction For The Administration Of Medicines Included In The Sepsis Formulary To Adults With Suspected Sepsis By Registered Nurses Working In Community Hospitals Within NHS Grampian Lead

More information

Modified Early Warning Score Policy.

Modified Early Warning Score Policy. Trust Policy and Procedure Modified Early Warning Score Policy. Document ref. no: PP(15)271 For use in (clinical areas): For use by (staff groups): For use for (patients): Document owner: Status: All clinical

More information

Please call the Pharmacy Medicines Unit on or for a copy.

Please call the Pharmacy Medicines Unit on or for a copy. Title: PATIENT GROUP DIRECTION FOR THE SUPPLY OF FLUCONAZOLE 150MG UNDER THE MINOR AILMENT SERVICE Identifier: Across NHS Boards Organisation Wide Directorate Clinical Service Sub Department Area This

More information

Health and Safety Policy

Health and Safety Policy Health and Safety Policy NHS Leeds rth Clinical Commissioning Group NHS Leeds South and East Clinical Commissioning Group NHS Leeds West Clinical Commissioning Group Version: 2.1 Ratified by: NHS Leeds

More information

NON-MEDICAL PRESCRIBING POLICY

NON-MEDICAL PRESCRIBING POLICY NON-MEDICAL PRESCRIBING POLICY To be read in conjunction with the Medicines Policy, Controlled Drug Policy and the FP10 Prescribing Forms Policy Version: 5 Date of issue: August 2017 Review date: August

More information

WORKING DRAFT. Standards of proficiency for nursing associates. Release 1. Page 1

WORKING DRAFT. Standards of proficiency for nursing associates. Release 1. Page 1 WORKING DRAFT Standards of proficiency for nursing associates Page 1 Release 1 1. Introduction This document outlines the way that we have developed the standards of proficiency for the new role of nursing

More information

Section 6: Referral record headings

Section 6: Referral record headings Section 6: Referral record headings Referral record standards: the referral headings are primarily intended for recording the clinical information in referral communication between general practitioners

More information

Patient Group Direction For the supply of Fusidic Acid 2% Cream

Patient Group Direction For the supply of Fusidic Acid 2% Cream Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may

More information

JOB DESCRIPTION. Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine

JOB DESCRIPTION. Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine JOB DESCRIPTION Job Title: Department: Medicine - Haematology Day Care Unit Reports to: Lead Haematology/Chemotherapy Clinical Nurse Specialist Head of Nursing Medicine Liaises with: Lead Haematology/Chemotherapy

More information

Health & Safety Policy. Author:

Health & Safety Policy. Author: Title: Reference No: Owner: Author: Health & Safety Policy 0010/Corporate Chief Officer Competent Person for Health and Safety Ruth Nutbrown CMIOSH First Issued On: Governing Body 4 December 2013 Latest

More information

Specialised Services: CPL-008 Referral Management Policy

Specialised Services: CPL-008 Referral Management Policy Specialised Services: CPL-008 Referral Management Policy 2017 Version 2.0 Document information Document purpose Document name Policy Referral Management Policy Author Welsh Health Specialised Services

More information

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board

INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY. Suffolk GP Federation Board INDEPENDENT NON-MEDICAL PRESCRIBING (NMPs) POLICY Version: 1.0 Policy owner: Ratified by: Clinical Governance Lead Chief Executive Date approved: 28 th November 2014 Approved by: Suffolk GP Federation

More information

Hospital Discharge and Transfer Guidance. Choice, Responsiveness, Integration & Shared Care

Hospital Discharge and Transfer Guidance. Choice, Responsiveness, Integration & Shared Care Hospital Discharge and Transfer Guidance Choice, Responsiveness, Integration & Shared Care Worcestershire Mental Health Partnership NHS Trust Information Reader Box Document Type: Document Purpose: Unique

More information

Date of publication:june Date of inspection visit:18 March 2014

Date of publication:june Date of inspection visit:18 March 2014 Jubilee House Quality Report Medina Road, Portsmouth PO63NH Tel: 02392324034 Date of publication:june 2014 www.solent.nhs.uk Date of inspection visit:18 March 2014 This report describes our judgement of

More information

Expiry Date: January 2009 Template Version: Page 1 of 7

Expiry Date: January 2009 Template Version: Page 1 of 7 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: Inclusion criteria: Patients who require an antihistamine

More information

SAFEGUARDING CHILDREN POLICY

SAFEGUARDING CHILDREN POLICY SAFEGUARDING CHILDREN POLICY The child s needs are paramount, and the needs and wishes of each child, be they a baby or infant, or an older child, should be put first Working Together 2015 p 8 Keeping

More information

Consultation Group: See relevant page in the PGD. Review Date: October 2016

Consultation Group: See relevant page in the PGD. Review Date: October 2016 Patient Group Direction For The Administration Of Adrenaline (Epinephrine) By Trained Nurses In The Management Of Cardiac Arrest In The Medical High Dependency Unit/Coronary Care Unit (MHDU/CCU) Working

More information

Recognising a Deteriorating Patient. Study guide

Recognising a Deteriorating Patient. Study guide Recognising a Deteriorating Patient Study guide Recognising a deteriorating patient Recognising and responding to clinical deterioration Background Clinical deterioration can occur at any time in a patient

More information

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy

The Newcastle upon Tyne Hospitals NHS Foundation Trust. Injectable Medicines Policy The Newcastle upon Tyne Hospitals NHS Foundation Trust Injectable Medicines Policy Version No.: 4.3 Effective From: 24 March 2017 Expiry Date: 21 January 2019 Date Ratified: 11 January 2017 Ratified By:

More information

GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT

GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT GG&C PGD ref no: 2018/1562 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults

More information

NHS Greater Glasgow & Clyde Patient Group Direction (PGD) for Healthcare Professionals Typhoid vaccine (intra muscular administration)

NHS Greater Glasgow & Clyde Patient Group Direction (PGD) for Healthcare Professionals Typhoid vaccine (intra muscular administration) GG&C PGD ref no: 2017/1523 YOU MUST BE AUTHORISED BY NAME, UNDER THE CURRENT VERSION OF THIS PGD BEFORE YOU ATTEMPT TO WORK ACCORDING TO IT Clinical Condition Indication: For active immunisation in adults

More information